Featured Author Podcast: Sugammadex Use in Renal Impairment
Anesthesiology Journal's podcast
Release Date: 05/07/2025
Anesthesiology Journal's podcast
Creator: James P. Rathmell, M.D. Overview of October issue original studies.
info_outlineAnesthesiology Journal's podcast
Moderator: James Rathmell, M.D. Participants: Ji-Hyun Lee, M.D., Ph.D. and Andrew J. Davidson, M.D., M.B.B.S. Articles Discussed:
info_outlineAnesthesiology Journal's podcast
Moderator: James Rathmell, M.D. Participants: Shiqian Shen, M.D. and Cyrus David Mintz, M.D., Ph.D. Articles Discussed:
info_outlineAnesthesiology Journal's podcast
Moderator: BobbieJean Sweitzer, M.D. Participants: Bernd Saugel, M.D. and Michael R. Mathis, M.D. Articles Discussed:
info_outlineAnesthesiology Journal's podcast
Creator: James P. Rathmell, M.D. Overview of September issue original studies.
info_outlineAnesthesiology Journal's podcast
Moderator: James P. Rathmell, M.D. Participants: Nikolay O. Kamenshchikov, M.D. and Lorenzo Berra, M.D. and Kamrouz Ghadimi, M.D. Articles Discussed:
info_outlineAnesthesiology Journal's podcast
Moderator: James P. Rathmell, M.D. Participants: Paul Lee-Archer and Clyde Matava, M.B.Ch.B., M.Med., M.H.S.C. Articles Discussed:
info_outlineAnesthesiology Journal's podcast
Creator: James P. Rathmell, M.D. Overview of August issue original studies.
info_outlineAnesthesiology Journal's podcast
Moderator: James P. Rathmell, M.D. Participants: Albert Garcia-Casanovas, M.H.A. and Douglas Colquhoun, M.B., M.Sc., M.P.H. Articles Discussed:
info_outlineAnesthesiology Journal's podcast
Moderator: BobbieJean Sweitzer, M.D. Participants: Jessica R Ansari, M.D., M.S. and Craig M. Palmer, M.D. Articles Discussed:
info_outlineModerator: BobbieJean, M.D.
Participants: Douglas Colquhoun, M.B., M.Sc., M.P.H. and Stephan R. Thilen
Articles Discussed:
Neuromuscular Blockade and Antagonism in Patients with Renal Impairment: A Multicenter Retrospective Cross Sectional Study
On and Off Label Use of Sugammadex in Patients with Renal Impairment in the 6 ½ Years Following FDA Approval
Transcript